Literature DB >> 16189132

Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.

John Casey1, Paul J Cote, Illia A Toshkov, Chung K Chu, John L Gerin, William E Hornbuckle, Bud C Tennant, Brent E Korba.   

Abstract

In a small controlled study, clevudine, a potent inhibitor of hepadnaviruses, including hepatitis B virus and woodchuck hepatitis virus, suppressed hepatitis delta virus (HDV) viremia in chronically infected woodchucks. Suppression was correlated with the marked reduction of woodchuck hepatitis virus surface antigen in individual animals, consistent with the concept that repression of surface antigen expression may be a useful antiviral strategy for HDV.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16189132      PMCID： PMC1251514          DOI： 10.1128/AAC.49.10.4396-4399.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  37 in total

1.  Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.

Authors:  M Y Kuo; M Chao; J Taylor
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

2.  The predominance of hepatitis delta virus genotype I among chronically infected Italian patients.

Authors:  G A Niro; A Smedile; A Andriulli; M Rizzetto; J L Gerin; J L Casey
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

Review 3.  Advances in hepatitis D virus biology and disease.

Authors:  A Smedile; M Rizzetto; J L Gerin
Journal:  Prog Liver Dis       Date:  1994

4.  A preliminary trial of lamivudine for chronic hepatitis B infection.

Authors:  J L Dienstag; R P Perrillo; E R Schiff; M Bartholomew; C Vicary; M Rubin
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

5.  Experimental transmission of human hepatitis delta virus to the laboratory mouse.

Authors:  H J Netter; K Kajino; J M Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line.

Authors:  J C Wu; P J Chen; M Y Kuo; S D Lee; D S Chen; L P Ting
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Assembly of hepatitis delta virus particles.

Authors:  W S Ryu; M Bayer; J Taylor
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Treatment of chronic hepatitis D with interferon alfa-2a.

Authors:  P Farci; A Mandas; A Coiana; M E Lai; V Desmet; P Van Eyken; Y Gibo; L Caruso; S Scaccabarozzi; D Criscuolo
Journal:  N Engl J Med       Date:  1994-01-13       Impact factor: 91.245

9.  Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens.

Authors:  C Sureau; A M Moriarty; G B Thornton; R E Lanford
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Serial transmission of spongiocytic hepatitis to woodchucks (possible association with a specific delta strain).

Authors:  R Parana; F Gerard; J L Lesbordes; C Pichoud; L Vitvitski; L G Lyra; C Trepo
Journal:  J Hepatol       Date:  1995-04       Impact factor: 25.083
View more
  11 in total

Review 1.  Antiviral therapy and resistance with hepatitis B virus infection.

Authors:  Hans L Tillmann
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Action of inhibitors on accumulation of processed hepatitis delta virus RNAs.

Authors:  Jinhong Chang; Xingcao Nie; Severin Gudima; John Taylor
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Molecular and clinical aspects of hepatitis D virus infections.

Authors:  Elham Shirvani Dastgerdi; Ulf Herbers; Frank Tacke
Journal:  World J Virol       Date:  2012-06-12

Review 4.  Aging and HIV/AIDS: pathogenetic role of therapeutic side effects.

Authors:  Rebecca A Torres; William Lewis
Journal:  Lab Invest       Date:  2013-12-16       Impact factor: 5.662

Review 5.  Mirror-Image Oligonucleotides: History and Emerging Applications.

Authors:  Brian E Young; Nandini Kundu; Jonathan T Sczepanski
Journal:  Chemistry       Date:  2019-04-26       Impact factor: 5.236

Review 6.  Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.

Authors:  Heiner Wedemeyer; Michael P Manns
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

Review 7.  Therapy of Delta Hepatitis.

Authors:  Cihan Yurdaydin; Ramazan Idilman
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-07       Impact factor: 6.915

8.  Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks.

Authors:  Natalia Freitas; Jessica Salisse; Celso Cunha; Ilia Toshkov; Stephan Menne; Severin O Gudima
Journal:  Hepatology       Date:  2012-04-25       Impact factor: 17.425

9.  Hepatitis d.

Authors:  Elif S Koytak; Cihan Yurdaydin; Jeffrey S Glenn
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

10.  Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.

Authors:  Natalia Freitas; Celso Cunha; Stephan Menne; Severin O Gudima
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.